GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Notes Receivable

Psomagen (XKRX:950200) Notes Receivable : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Psomagen Notes Receivable?

Psomagen's Notes Receivable for the quarter that ended in Mar. 2024 was ₩0 Mil.


Psomagen Notes Receivable Historical Data

The historical data trend for Psomagen's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Notes Receivable Chart

Psomagen Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial - - - - -

Psomagen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Psomagen Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Psomagen Notes Receivable Related Terms

Thank you for viewing the detailed overview of Psomagen's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Psomagen (XKRX:950200) Business Description

Traded in Other Exchanges
N/A
Address
1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850
Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines